These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8521769)

  • 61. Impotence: treatment by autoinjection of vasoactive drugs.
    Desai KM; Gingell JC
    Br Med J (Clin Res Ed); 1987 Oct; 295(6603):922. PubMed ID: 3119102
    [No Abstract]   [Full Text] [Related]  

  • 62. Intracavernous injection of papaverine, phentolamine and phenoxybenzamine.
    Pettirossi O; Serenelli G
    Acta Urol Belg; 1988; 56(2):211-9. PubMed ID: 3400527
    [No Abstract]   [Full Text] [Related]  

  • 63. Effectiveness of vardenafil versus papaverine in penile Doppler ultrasonography.
    Ardicoglu A; Kocakoc E; Tuygun UO; Bozgeyik Z; Orhan I
    Urol Int; 2005; 75(1):75-9. PubMed ID: 16037713
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Topical therapy in erectile dysfunction].
    Floth A
    Wien Med Wochenschr; 2000; 150(1-2):14-7. PubMed ID: 10746290
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Purulent corporeal cavernositis secondary to papaverine-induced priapism.
    Schwarzer JU; Hofmann R
    J Urol; 1991 Sep; 146(3):845-6. PubMed ID: 1875509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vasoactive intestinal polypeptide/phentolamine for intracavernosal injection in erectile dysfunction.
    Dinsmore WW; Wyllie MG
    BJU Int; 2008 Sep; 102(8):933-7. PubMed ID: 18485029
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Non-invasive management of impotence with transcutaneous nitroglycerin.
    Meyhoff HH; Rosenkilde P; Bødker A
    Br J Urol; 1992 Jan; 69(1):88-90. PubMed ID: 1737261
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases.
    Bardin ED; Krieger JN
    Int Urol Nephrol; 1990; 22(2):147-52. PubMed ID: 2354895
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Vasomax for the treatment of male erectile dysfunction.
    Goldstein I; Carson C; Rosen R; Islam A
    World J Urol; 2001 Feb; 19(1):51-6. PubMed ID: 11289571
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Our experience in the treatment of priapism.
    Vorobets D; Banyra O; Stroy A; Shulyak A
    Cent European J Urol; 2011; 64(2):80-3. PubMed ID: 24578869
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Re: Physiology of erection and pharmacological management of impotence.
    Zorgniotti AW
    J Urol; 1988 Feb; 139(2):387. PubMed ID: 3339756
    [No Abstract]   [Full Text] [Related]  

  • 72. Papaverine hydrochloride containing nanostructured lyotropic liquid crystal formulation as a potential drug delivery system for the treatment of erectile dysfunction.
    Berkó S; Zsikó S; Deák G; Gácsi A; Kovács A; Budai-Szűcs M; Pajor L; Bajory Z; Csányi E
    Drug Des Devel Ther; 2018; 12():2923-2931. PubMed ID: 30254422
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intracavernous pharmacotherapy: treatment for the aging erectile response.
    Broderick GA
    Urol Clin North Am; 1996 Feb; 23(1):111-26. PubMed ID: 8677530
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Creative-dynamic image synthesis: a useful addition to the treatment options for impotence.
    Sommer F; Obenaus K; Engelmann U
    Int J Impot Res; 2001 Oct; 13(5):268-74; discussion 275. PubMed ID: 11890513
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Therapeutic effects of high dose yohimbine hydrochloride on organic erectile dysfunction.
    Telöken C; Rhoden EL; Sogari P; Dambros M; Souto CA
    J Urol; 1998 Jan; 159(1):122-4. PubMed ID: 9400452
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of yohimbine-trazodone on psychogenic impotence: a randomized, double-blind, placebo-controlled study.
    Montorsi F; Strambi LF; Guazzoni G; Galli L; Barbieri L; Rigatti P; Pizzini G; Miani A
    Urology; 1994 Nov; 44(5):732-6. PubMed ID: 7974947
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Double-blind trial of yohimbine in treatment of psychogenic impotence.
    Reid K; Surridge DH; Morales A; Condra M; Harris C; Owen J; Fenemore J
    Lancet; 1987 Aug; 2(8556):421-3. PubMed ID: 2887726
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in impotence.
    Marquer C; Bressolle F
    Fundam Clin Pharmacol; 1998; 12(4):377-87. PubMed ID: 9711459
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Yohimbine in erectile dysfunction: would an orphan drug ever be properly assessed?
    Morales A
    World J Urol; 2001 Aug; 19(4):251-5. PubMed ID: 11550783
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Topical agents and erectile dysfunction: is there a place?
    Yap RL; McVary KT
    Curr Urol Rep; 2002 Dec; 3(6):471-6. PubMed ID: 12425870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.